Reply to R. Warsame et al

Affiliations

¹ University of Heidelberg, Heidelberg, Germany.
² German Cancer Research Center, Heidelberg, Germany.
³ University of Heidelberg, Heidelberg, Germany Stefan.schoenland@med.uni-heidelberg.de.

Comment

Tilmann Bochtler et al. J Clin Oncol. 2015.

. 2015 Nov 20;33(33):3976-7.

doi: 10.1200/JCO.2015.63.2141. Epub 2015 Aug 31.

¹ University of Heidelberg, Heidelberg, Germany.
² German Cancer Research Center, Heidelberg, Germany.
³ University of Heidelberg, Heidelberg, Germany Stefan.schoenland@med.uni-heidelberg.de.

No abstract available

Comment on

Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens.
Bochtler T, Hegenbart U, Kunz C, Granzow M, Benner A, Seckinger A, Kimmich C, Goldschmidt H, Ho AD, Hose D, Jauch A, Schönland SO. Bochtler T, et al. J Clin Oncol. 2015 Apr 20;33(12):1371-8. doi: 10.1200/JCO.2014.57.4947. Epub 2015 Mar 16. J Clin Oncol. 2015. PMID: 25779559
Blaming the Right Fluorescent in Situ Hybridization.
Warsame R, Dispenzieri A. Warsame R, et al. J Clin Oncol. 2015 Nov 20;33(33):3976. doi: 10.1200/JCO.2015.62.3876. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324369 No abstract available.